Company
Alliance Pharma PLC
LON:APH
Alliance Pharma PLC is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries. The company holds marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are managed on a portfolio basis according to their growth potential.
156 stories · page 1 of 2
UK CMA launches High Court disqualification order against Alliance Pharma CEO
Alliance said it "did not participate in, or profit from, any market sharing arrangement and refutes any involvement by the company" or its CEO Peter Butterfield
Archive
Market Movers: Instem advances after $12mln contract win
A look at some risers and fallers in the market on Friday.
Alliance Pharma saw strong first-half performance
"We expect the group's strong performance will continue throughout the second half and anticipate this will have a positive impact on cash generation,” said Peter Butterfield
Alliance Pharma appoints top Walgreens-Boots-Alliance manager as non-executive director
Kristof Neirynck will join as an independent non-executive director in December
Alliance Pharma chairman says integration of Biogix and Amberen is largely complete
David Cook provided the short update ahead of the company's AGM later Wednesday
Alliance Pharma's impressive consumer healthcare playbook underrated says RBC
Almost three-quarters of Alliance’s revenues now come from consumer healthcare with superior growth
Alliance Pharma triples dividend as it integrates Biogix acquisition and eyes others
"Whilst our near-term focus will be on integrating Biogix into our existing US business, we will continue to look for opportunities to selectively add to our portfolio," said chief executive Peter Butterfield
Archive
ADM Energy jumps on news of possible fundraising and Nigerian investment
A look at the major movers on the London stock market on Thursday
Alliance Pharma says profit to be marginally ahead of forecasts despite coronavirus pandemic challenges
The healthcare products firm also said its cash flow in 2020 has "remained very strong", bolstered by favourable movements in net working capital
Alliance Pharma beefs up US arm with menopause treatment supplement
Amberen is expected to become Alliance's second-largest brand
Alliance Pharma holds dividend as recovery from coronavirus disruption continues
The company’s flagship consumer healthcare brands were helped by a strong performance from scar prevention treatment Kelo-cote
Alliance Pharma starting to see some good signs of recovery
The disruption caused by the coronavirus pandemic has had an effect on revenues but things have been picking up of late, especially in China
Alliance Pharma rises as consumer confidence returns to Chinese market
CEO Peter Butterfield also said the company had not experienced “any significant supply disruption” due to the coronavirus pandemic
Alliance Pharma delivers strong set of prelims
In common a growing band of businesses it has decided to pass on the dividend in order to conserve cash
Alliance Pharma looks to second half recovery in Asia
The group's supply chain is holding up well, Alliance said
Alliance Pharma firing on all cylinders as revenues grow 16% and net debt tumbles
The stand-out performer, growing 38%, was scar reduction treatment Kelo-cote
Alliance Pharma hands back Xonvea rights
Some £2mln in milestone payments made to Duchesnay of Canada will be returned
Alliance Pharma: Star brands and Asia underpin drugs group's financial performance
The company said it was on track to hit full-year expectations as it delivered a solid first-half performance
Alliance Pharma on track to hit full-year expectations as star brands and Asia underpin first-half performance
“Our strong underlying growth and cash generation, coupled with the enhanced banking facilities, mean we are well positioned to pursue future growth opportunities,” added CEO Peter Butterfield
Alliance Pharma happy with two-pronged strategy
“It’s a blended model of highly cash generative assets and top line growth”
Alliance Pharma sales rise as star brands perform
Sales were strong in Europe and international markets, especially China
Investments and investor services
FTSE 100 closes higher, bolstered by sterling's fall; rate rise doubts
The index of leading UK shares closed up just shy of 50 points higher at 7,676, while the FTSE 250 was also up
As Ryanair's struggles continue can easyjet look to the blue skies?
Easyjet and Severn Treant are among the key names in the diary for Wednesday.
Alliance Pharma building a head of steam in Asia Pacific
Alliance is continuing to build significant growth drivers into its business, Numis Securities asserts. The company's house broker is forecasting 10% revenue growth from 2018 to 2020
Archive
Week ahead: Investors hope Royal Mail delivers the goods and Unilever meets targets
The week ahead includes updates from Royal Mail, Unilever, Sports Direct, Rio Tinto and Anglo American along with official UK data on jobs, inflation and retail sales
Archive
Proactive news snapshot: ECR Minerals, FairFX Group, Hurricane Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Wilmington shares fall as it predicts low revenue growth
A look at some of the top risers and fallers in London on Friday
Alliance Pharma’s morning sickness drug gets marketing authorisation in the UK
The AIM-listed pharmaceutical company also said that the MHRA has approved the brand name Xonvea, which will be used for marketing Dicelctin in the UK
FTSE 100 closes in positive territory but is down on week as trade tensions continue to blight markets
Benchmarks on Wall Street are trading higher, with the Dow Jones Industrial Average up 116 points
Investments and investor services
Hvivo continues to soar as investors look ahead to next flu vaccine trial
A look at some of the biggest risers and fallers in London.
Archive
Proactive news snapshot: Taptica International, Powerhouse Energy, Haydale Graphene …
A glance at some of the day's highlights from the Proactive Investors newswire
Alliance Pharma makes £60mln swoop for Asia-Pacific rights to top-selling anti-dandruff shampoo
The new product will be the company's fourth international star brand
Investments and investor services
FTSE 100 closes in red for second day this week as Trump trade threats turn real
The market has been seeming complacent on Trump’s tough protectionist rhetoric..until now
Archive
Proactive news snapshot: Sound Energy, Alliance Pharma, Feedback …
A glance at some of the day's highlights from the Proactive Investors newswire
Goldstone Resources surges after confirming high-grade gold at Akrokeri
A look at some of the biggest risers and fallers in London on Thursday
Alliance Pharma gets boost as morning sickness drug gets UK regulatory green light
Chief executive Peter Butterfield said: "We are delighted by this news and look forward to launching Diclectin later this year."
FTSE 100 ends in the red as Brexit wrangling weighs on sentiment
The UK's premier share index closed down 7.97 points, or 0.10% at 7,704
Archive
Proactive news snapshot: Landore Resources, Vast Resources, Live Company …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
IDE appoints IT veteran Ian Smith to oversee strategic and operational review
A look at the day's major share price movers, including Clontarf Energy, De La Rue and Photo-Me
Archive
FTSE 100 has late flurry to close firmly higher
The UK blue-chip index had a surge near the close of play and added nearly 57 points
Archive
Markets
Ascent Resources climbs as formal sale process started after producing revenues in 2017
Some of the top news-driven risers in London at 3.45pm ...
Alliance Pharma to bank £2.9mln from the sale of Chinese rights to pregnancy supplement
A £1.5mln shareholder loan will also be repaid, the company told investors
Archive
Proactive news snapshot: Falcon Oil & Gas, ITM Power, OptiBiotix Health …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Is DFS Furniture really sitting comfortably despite tough market conditions?
The sofa seller is bedding in its recently acquired business and last month said its second quarter was 'on track', nevertheless, the City sees a challenging market for big ticket retail.
Elecosoft shares rise as dividend hiked in full-year results
A look at some of the biggest risers and fallers in London on Tuesday
Alliance Pharma hikes dividend after strong 2017 earnings
"We are well positioned to pursue growth both organically and through further acquisitions in 2018,” said chairman David Cook
FTSE 100 stages rebound as trade war fears ease
In the currency markets, the pound shed 0.17% against the Euro, and lost 0.46% against the US dollar
Archive
Ferguson's organic growth rates are likely to be the main points of interest
Also previewed: Irn-Bru maker AG Barr and water company United Utilities
Archive
Utilities dominate week ahead with updates from Pennon, United Utilities and SSE
The week ahead includes trading updates from Pennon, United Utilities and SSE, along with interims from DFS Furniture and full year results from Moss Bros and AG Barr
Archive
Proactive news snapshot: Asiamet Resources, Tekcapital, Plastics Capital …
A glance at some of the day's highlights from the Proactive Investors newswire
Tandem says cost control measures have returned bicycle operations to profitability
"We are cautious about the outlook for the year ahead, but we remain confident that we have the resources and personnel to deliver profitability to our shareholders," Tandem said.
Alliance Pharma unveils big board reshuffle with deputy CEO to become CEO, and a new chairman
The AIM-listed speciality pharmaceutical group said Peter Butterfield, currently deputy CEO, will take over from John Dawson as CEO on 1 May 2018
Investments and investor services
FTSE 100 closes firmly lower as global share rout continues
Investors didn't want to venture into shares today, or outside much in the UK for that matter
TyraTech confirms it is proceeding with Vamousse sale to Alliance Pharma
Tyratech shares were up around 10% on Thursday while Alliance also edged into positive territory
Investments and investor services
FTSE 100 steadies at record high, driven by mining shares
The FTSE 100 finished little changed at 7,622 on the back of a rally in mining shares.
Archive
Proactive news snapshot: Alliance Pharma, TyraTech, Galileo Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Elegant Hotels rejects bid approach from Melia Hotels
By the time it has confirmed press speculation, the bid approach was a dead duck
Alliance Pharma brings on board its third international product with US$17.5mln Vamousse deal
It is paying an initial US$13mln for Vamousse, which it is acquiring from TyraTech, the AIM-listed developer of the range. This will be followed by a deferred pay-out of as much as US$4.5mln based on sales targets
Alliance Pharma brings on board its third international product with US$17.5mln Vamousse deal
It is paying an initial US$13mln for Vamousse, which it is acquiring from TyraTech plc, the AIM-listed developer of the range. This will be followed by a deferred pay-out of as much as US$4.5mln based on sales targets
FTSE 100 closes higher; miners lag and Brexit wranglings continue
FTSE 100 closed over 38 points higher on the day to 7,338; FTSE 250 shares added over 81
Archive
Proactive news snapshot: Rose Petroleum, LEKOIL, Diversified Gas & Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Broker downgrades send Royal Mail and Babcock International lower
Some of the biggest risers and fallers in London on Friday.
Alliance Pharma buys rights to anaesthetic gel product, Ametop from Smith & Nephew for US$7.5mln
John Dawson, Alliance Pharma's chief executive, said: "The acquisition will be immediately earnings enhancing, accretive to our underlying return on invested capital, and it fits well in our existing bedrock business operations"
Investments and investor services
FTSE 100 slides as Trump impeachment fears resurface
The Teflon president faced another test of his lucky rabbit's foot's effectiveness
Archive
Proactive news snapshot: Clinigen, Braveheart Investment, Alliance Pharma
A glance at some of the day's highlights from the Proactive Investors newswire
John Lewis of Hungerford serves up a treat for relieved investors
Some of the main news driven risers and fallers at 3.40pm…
Cash generative Alliance Pharma poised for further growth
The specialty pharmaceutical company generated over £11mln of cash
FTSE 100 closes 21 pts lower as miners weigh
The heavyweight dragged on the FTSE 100, which closed down 20.99 points
Archive
Galliford Try full year profits to be hit by £98m one-off charge for legacy contracts
Wednesday's calendar includes annual results from Galliford Try and Dunelm along with official UK jobs data
Archive
Carney & Co in the crosshairs, plus key UK data and updates from Next, Morrisons and Wetherspoon
Week ahead includes latest Bank of England policy meeting, UK data on inflation, unemployment, wages and retail sales, plus corporate updates from Next, Associated British Foods, Wm Morrison Supermarkets, and JD Wetherspoon
Alliance Pharma - a business in rude health
The company has made the transition from a business capitalised at £90mln to company now worth around a quarter of a billion pounds - but has the market at large picked up on (and priced in) the transformation?
Archive
Proactive news snapshot: Premier African Minerals, Powerhouse Energy, Widecells...
Some of the day's headlines on the Proactive Investors newswire
Contract news lift for Physiomics, Rosslyn Data Technologies
A glance at some of the bigger risers and fallers today in London ...
Alliance Pharma updates on Diclectin
“Whilst this is disappointing news, this will have no material impact on the company's expected near-term results.”
FTSE 100 manages to hold onto gains; Severn Trent top gainer
With an hour and a half of trading to go in London, the FTSE 100 index was 36 points higher at 7,404, albeit remaining below an early peak of 7,425.52
Archive
Proactive news snapshot: Kin Group, Allergy Therapeutics, 88 Energy ...
A glance at some of the stories on the Proactive newswire today
Investments and investor services
IG Group: up the polls!
Companies featured: HaloSource, Ascent Resources, Inspirit Energy, Clear Leisure, Safestyle, Nyota MInerals, IG Group, Polemos, Ortac Resources
Alliance Pharma says overall trading in first half in line with board's expectations, with sales seeing a solid increase
In a pre-close trading update, the specialty pharmaceutical company said it performed well in the first half with sales for the period up 8% at £50.3mln, against £46.4mln at the same stage in 2016
Investments and investor services
FTSE 100 closes lower after up and down day
FTSE 100 had a bumpy ride on the day and closed almost 14 points down at 7,390...
Archive
Royal Mail to deliver latest trading update; UK inflation numbers the key focus
Day ahead: Updates from Royal Mail, Rio Tinto; UK June inflation numbers ...
Archive
Unilever results to illustrate strategy review boosts; investors looking for Vodafone improvements
Week Ahead: Unilever PLC, Vodafone PLC, easyJet PLC, Sports Direct PLC, Royal Mail Group PLC ...
Archive
Proactive new round-up: Savannah Resources, Minds + Machines , Redx Pharma..
A glance at some of the stories on the Proactive newswire today...
Alliance Pharma heads higher after upbeat AGM statement
Trading is good and cash flow is strong, while UK regulatory approval for its Diclectin nausea treatment is still expected in the third quarter.
Starvest heads for the moon as it praises Ariana Resources investment
Some of the main risers and fallers in London at 3.45pm
FTSE 100 trades sideways as big oilers dented by OPEC decision
FTSE 100 closed at 7,517 - up 2.81. points, or 0.04% and failed to make a record close